Leukemia, Prolymphocytic, T-Cell
"Leukemia, Prolymphocytic, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.
| Descriptor ID |
D015461
|
| MeSH Number(s) |
C04.557.337.428.565.750 C04.557.337.428.580.125 C15.604.515.560.550.750 C15.604.515.560.575.125 C20.683.515.528.565.750 C20.683.515.528.582.125
|
| Concept/Terms |
Leukemia, Prolymphocytic, T-Cell- Leukemia, Prolymphocytic, T-Cell
- T-Cell Prolymphocytic Leukemia
- Leukemia, T-Cell Prolymphocytic
- Leukemias, T-Cell Prolymphocytic
- Prolymphocytic Leukemia, T-Cell
- Prolymphocytic Leukemias, T-Cell
- T Cell Prolymphocytic Leukemia
- T-Cell Prolymphocytic Leukemias
Leukemia, T Cell, Chronic- Leukemia, T Cell, Chronic
- Leukemia, Lymphocytic, Chronic, T-Cell
- T-Lymphocytic Leukemia, Chronic
- Lymphocytic Leukemia, T Cell, Chronic
- Lymphocytic Leukemia, T-Cell, Chronic
- T-Cell Leukemia, Chronic
- Leukemia, Lymphocytic, Chronic, T Cell
- Leukemia, T-Cell, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Prolymphocytic, T-Cell".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Leukemia [C04.557.337]
- Leukemia, Lymphoid [C04.557.337.428]
- Leukemia, Prolymphocytic [C04.557.337.428.565]
- Leukemia, Prolymphocytic, T-Cell [C04.557.337.428.565.750]
- Leukemia, T-Cell [C04.557.337.428.580]
- Leukemia, Prolymphocytic, T-Cell [C04.557.337.428.580.125]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Leukemia, Lymphoid [C15.604.515.560]
- Leukemia, Prolymphocytic [C15.604.515.560.550]
- Leukemia, Prolymphocytic, T-Cell [C15.604.515.560.550.750]
- Leukemia, T-Cell [C15.604.515.560.575]
- Leukemia, Prolymphocytic, T-Cell [C15.604.515.560.575.125]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Leukemia, Lymphoid [C20.683.515.528]
- Leukemia, Prolymphocytic [C20.683.515.528.565]
- Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.565.750]
- Leukemia, T-Cell [C20.683.515.528.582]
- Leukemia, Prolymphocytic, T-Cell [C20.683.515.528.582.125]
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Prolymphocytic, T-Cell".
This graph shows the total number of publications written about "Leukemia, Prolymphocytic, T-Cell" by people in this website by year, and whether "Leukemia, Prolymphocytic, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Prolymphocytic, T-Cell" by people in Profiles.
-
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study. Blood Adv. 2024 Feb 27; 8(4):842-845.
-
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia. 2023 09; 37(9):1919-1921.
-
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases. Am J Clin Pathol. 2023 04 04; 159(4):325-336.
-
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022 04; 28(4):187.e1-187.e10.
-
Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia. Leuk Lymphoma. 2022 04; 63(4):865-875.
-
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL). Leuk Lymphoma. 2020 02; 61(2):445-449.
-
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 2019 10 03; 134(14):1132-1143.
-
Indurated erythema of the neck and upper back. Int J Dermatol. 2019 Nov; 58(11):1255-1257.
-
T-cell prolymphocytic leukemia negative for surface CD3 and CD45. Blood. 2018 07 05; 132(1):111.
-
T-PLL: another check on the venetoclax list? Blood. 2017 12 07; 130(23):2447-2448.